These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 15315839)

  • 1. Intranasal delivery of chitosan-DNA vaccine generates mucosal SIgA and anti-CVB3 protection.
    Xu W; Shen Y; Jiang Z; Wang Y; Chu Y; Xiong S
    Vaccine; 2004 Sep; 22(27-28):3603-12. PubMed ID: 15315839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A novel DNA vaccine containing endosome-fusogenic peptide prevents CVB3-induced myocarditis in mice].
    Xu W; Shen Y; Chen RZ; Xiong SD
    Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):334-8. PubMed ID: 15059520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of protective immune responses against coxsackievirus B3 challenge by DNA prime-protein boost vaccination.
    Lan J; Gao Z; Xiong H; Chuai X; Jin Y; Li J; Xian X; Liu G; Xie L; Zhang Y; Wang Y
    Vaccine; 2011 Sep; 29(40):6894-902. PubMed ID: 21803097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced resistance to coxsackievirus B3-induced myocarditis by intranasal co-immunization of lymphotactin gene encapsulated in chitosan particle.
    Yue Y; Xu W; Hu L; Jiang Z; Xiong S
    Virology; 2009 Apr; 386(2):438-47. PubMed ID: 19233446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of a DNA vaccine for coxsackievirus B3 in mice: protective effects of capsid proteins against viral challenge.
    Kim JY; Jeon ES; Lim BK; Kim SM; Chung SK; Kim JM; Park SI; Jo I; Nam JH
    Vaccine; 2005 Feb; 23(14):1672-9. PubMed ID: 15705471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immune effects of four coxsackievirus B3 VP1 DNA fusion vaccines in mice].
    Liu GX; Lan JM; Chuai X; Gao ZY; Jin YH; Zhang YH; Xie LX; Yin CF; Wang YX
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Feb; 26(2):103-6. PubMed ID: 20230664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incorporation of a bi-functional protein FimH enhances the immunoprotection of chitosan-pVP1 vaccine against coxsackievirus B3-induced myocarditis.
    Fan X; Yue Y; Xiong S
    Antiviral Res; 2017 Apr; 140():121-132. PubMed ID: 28137624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [C3d enhances immune response to the secreted form of Coxsackie virus B3 VP1 DNA vaccine].
    Zhao N; Han XY; Wang XL; Li J; Li W; Xie LX; Li L; Wang YX
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(36):2561-3. PubMed ID: 18067834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. M cell-targeting strategy facilitates mucosal immune response and enhances protection against CVB3-induced viral myocarditis elicited by chitosan-DNA vaccine.
    Ye T; Yue Y; Fan X; Dong C; Xu W; Xiong S
    Vaccine; 2014 Jul; 32(35):4457-4465. PubMed ID: 24958702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of systems for delivering antigens and plasmid DNA for intranasal immunization against tick-borne encephalitis virus.
    Goncharova EP; Ryzhikov AB; Bulychev LE; Sizov AA; Lebedev LR; Poryvaev VD; Karpenko LI; Il'ichev AA
    Wien Klin Wochenschr; 2002 Jul; 114(13-14):630-5. PubMed ID: 12422616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal immunization with high-mobility group box 1 in chitosan enhances DNA vaccine-induced protection against coxsackievirus B3-induced myocarditis.
    Wang M; Yue Y; Dong C; Li X; Xu W; Xiong S
    Clin Vaccine Immunol; 2013 Nov; 20(11):1743-51. PubMed ID: 24027262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-15 enhance DNA vaccine elicited mucosal and systemic immunity against foot and mouth disease virus.
    Wang X; Zhang X; Kang Y; Jin H; Du X; Zhao G; Yu Y; Li J; Su B; Huang C; Wang B
    Vaccine; 2008 Sep; 26(40):5135-44. PubMed ID: 18462848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses.
    Wang D; Christopher ME; Nagata LP; Zabielski MA; Li H; Wong JP; Samuel J
    J Clin Virol; 2004 Dec; 31 Suppl 1():S99-106. PubMed ID: 15567101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal co-immunization with AIM2 enhances protective SIgA response and increases prophylactic efficacy of chitosan-DNA vaccine against coxsackievirus B3-induced myocarditis.
    Chai D; Yue Y; Xu W; Dong C; Xiong S
    Hum Vaccin Immunother; 2014; 10(5):1284-94. PubMed ID: 24614684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasal immunization of mice with a rotavirus DNA vaccine that induces protective intestinal IgA antibodies.
    García-Díaz A; López-Andújar P; Rodríguez Díaz J; Montava R; Torres Barceló C; Ribes JM; Buesa J
    Vaccine; 2004 Dec; 23(4):489-98. PubMed ID: 15530697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A bivalent VP1 gene vaccine against Coxsackie virus B1/B3].
    Wu X; Zhao T; Tian Y
    Zhonghua Yi Xue Za Zhi; 2001 Apr; 81(8):480-4. PubMed ID: 11798923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of coxsackievirus B3 by VP2 mutation and its application as a vaccine against virus-induced myocarditis and pancreatitis.
    Park JH; Kim DS; Cho YJ; Kim YJ; Jeong SY; Lee SM; Cho SJ; Yun CW; Jo I; Nam JH
    Vaccine; 2009 Mar; 27(13):1974-83. PubMed ID: 19168108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenteric CD103
    Zhao H; Yang J; Qian Q; Wu M; Li M; Xu W
    Front Immunol; 2018; 9():2986. PubMed ID: 30619341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on combined immunization of rAd/MDC-VP1 and pcDNA3/MDC-VP1 against Coxsackievirus B3 challenge in mice].
    Yan LJ; Gao ZY; Li J; Lan JM; Jin YH; Xie LX; Chuai X; Wang YX
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Mar; 28(3):228-31. PubMed ID: 22394627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination with coxsackievirus B3 virus-like particles elicits humoral immune response and protects mice against myocarditis.
    Zhang L; Parham NJ; Zhang F; Aasa-Chapman M; Gould EA; Zhang H
    Vaccine; 2012 Mar; 30(13):2301-8. PubMed ID: 22306858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.